Skip to content

Inebilizumab

Uplizna, Trogarzo (inebilizumab) is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against B-lymphocyte antigen CD19.
Trade Name Uplizna, Trogarzo
Common Name Inebilizumab
Indication neuromyelitis optica
Drug Class Monoclonal antibodies: humanized, immunomodulating
Inebilizumab
Get full access now